Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival

C. Verhoef, F. A. Holman, S. M. Hussain, R. A. De Man, J. H.W. De Wilt, J. N.M. IJzermans

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the most common primary cancers in the world and the third most common cause of cancer mortality world-wide. Surgery is the gold standard in the treatment of patients with HCC. The prognosis is mainly determined by the underlying liver disease and recurrent rates. In the Western World, up to 30% of the patients with HCC have a non-cirrhotic liver. The main prognostic factor in this special group of patients are the recurrences. Most recurrences are intrahepatic; however, 30% of the recurrences are extrahepatic. The role of resection in case of intrahepatic recurrences is widely accepted, particularly in the non-cirrhotic liver. The role of resection in extrahepatic HCC recurrences is not well established and unknown among many physicians. We present two patients with HCC in a non-cirrhotic liver with extrahepatic recurrences and long-term survival after resection. The corresponding literature support an aggressive approach in case of extrahepatic HCC recurrence in selected cases : resectable metastasis, preserved liver function, absence of intracranial metastasis and control of the primary tumour. Further research is warranted because of the limited number of reports and the absence of randomized trials.

Original languageEnglish (US)
Pages (from-to)533-536
Number of pages4
JournalActa Chirurgica Belgica
Volume105
Issue number5
DOIs
StatePublished - Oct 2005

Fingerprint

Hepatocellular Carcinoma
Neoplasm Metastasis
Recurrence
Survival
Liver
Neoplasms
Western World
Liver Diseases
Physicians
Mortality
Research

Keywords

  • Hepatocellular carcinoma
  • Metastasis

ASJC Scopus subject areas

  • Surgery

Cite this

Verhoef, C., Holman, F. A., Hussain, S. M., De Man, R. A., De Wilt, J. H. W., & IJzermans, J. N. M. (2005). Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival. Acta Chirurgica Belgica, 105(5), 533-536. https://doi.org/10.1080/00015458.2005.11679776

Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival. / Verhoef, C.; Holman, F. A.; Hussain, S. M.; De Man, R. A.; De Wilt, J. H.W.; IJzermans, J. N.M.

In: Acta Chirurgica Belgica, Vol. 105, No. 5, 10.2005, p. 533-536.

Research output: Contribution to journalArticle

Verhoef, C, Holman, FA, Hussain, SM, De Man, RA, De Wilt, JHW & IJzermans, JNM 2005, 'Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival', Acta Chirurgica Belgica, vol. 105, no. 5, pp. 533-536. https://doi.org/10.1080/00015458.2005.11679776
Verhoef, C. ; Holman, F. A. ; Hussain, S. M. ; De Man, R. A. ; De Wilt, J. H.W. ; IJzermans, J. N.M. / Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival. In: Acta Chirurgica Belgica. 2005 ; Vol. 105, No. 5. pp. 533-536.
@article{69d4554fc3734c03aaeffc15151297a7,
title = "Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival",
abstract = "Hepatocellular carcinoma (HCC) is one of the most common primary cancers in the world and the third most common cause of cancer mortality world-wide. Surgery is the gold standard in the treatment of patients with HCC. The prognosis is mainly determined by the underlying liver disease and recurrent rates. In the Western World, up to 30{\%} of the patients with HCC have a non-cirrhotic liver. The main prognostic factor in this special group of patients are the recurrences. Most recurrences are intrahepatic; however, 30{\%} of the recurrences are extrahepatic. The role of resection in case of intrahepatic recurrences is widely accepted, particularly in the non-cirrhotic liver. The role of resection in extrahepatic HCC recurrences is not well established and unknown among many physicians. We present two patients with HCC in a non-cirrhotic liver with extrahepatic recurrences and long-term survival after resection. The corresponding literature support an aggressive approach in case of extrahepatic HCC recurrence in selected cases : resectable metastasis, preserved liver function, absence of intracranial metastasis and control of the primary tumour. Further research is warranted because of the limited number of reports and the absence of randomized trials.",
keywords = "Hepatocellular carcinoma, Metastasis",
author = "C. Verhoef and Holman, {F. A.} and Hussain, {S. M.} and {De Man}, {R. A.} and {De Wilt}, {J. H.W.} and IJzermans, {J. N.M.}",
year = "2005",
month = "10",
doi = "10.1080/00015458.2005.11679776",
language = "English (US)",
volume = "105",
pages = "533--536",
journal = "Acta Chirurgica Belgica",
issn = "0001-5458",
publisher = "ARSMB-KVBMG",
number = "5",

}

TY - JOUR

T1 - Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival

AU - Verhoef, C.

AU - Holman, F. A.

AU - Hussain, S. M.

AU - De Man, R. A.

AU - De Wilt, J. H.W.

AU - IJzermans, J. N.M.

PY - 2005/10

Y1 - 2005/10

N2 - Hepatocellular carcinoma (HCC) is one of the most common primary cancers in the world and the third most common cause of cancer mortality world-wide. Surgery is the gold standard in the treatment of patients with HCC. The prognosis is mainly determined by the underlying liver disease and recurrent rates. In the Western World, up to 30% of the patients with HCC have a non-cirrhotic liver. The main prognostic factor in this special group of patients are the recurrences. Most recurrences are intrahepatic; however, 30% of the recurrences are extrahepatic. The role of resection in case of intrahepatic recurrences is widely accepted, particularly in the non-cirrhotic liver. The role of resection in extrahepatic HCC recurrences is not well established and unknown among many physicians. We present two patients with HCC in a non-cirrhotic liver with extrahepatic recurrences and long-term survival after resection. The corresponding literature support an aggressive approach in case of extrahepatic HCC recurrence in selected cases : resectable metastasis, preserved liver function, absence of intracranial metastasis and control of the primary tumour. Further research is warranted because of the limited number of reports and the absence of randomized trials.

AB - Hepatocellular carcinoma (HCC) is one of the most common primary cancers in the world and the third most common cause of cancer mortality world-wide. Surgery is the gold standard in the treatment of patients with HCC. The prognosis is mainly determined by the underlying liver disease and recurrent rates. In the Western World, up to 30% of the patients with HCC have a non-cirrhotic liver. The main prognostic factor in this special group of patients are the recurrences. Most recurrences are intrahepatic; however, 30% of the recurrences are extrahepatic. The role of resection in case of intrahepatic recurrences is widely accepted, particularly in the non-cirrhotic liver. The role of resection in extrahepatic HCC recurrences is not well established and unknown among many physicians. We present two patients with HCC in a non-cirrhotic liver with extrahepatic recurrences and long-term survival after resection. The corresponding literature support an aggressive approach in case of extrahepatic HCC recurrence in selected cases : resectable metastasis, preserved liver function, absence of intracranial metastasis and control of the primary tumour. Further research is warranted because of the limited number of reports and the absence of randomized trials.

KW - Hepatocellular carcinoma

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=27744471890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744471890&partnerID=8YFLogxK

U2 - 10.1080/00015458.2005.11679776

DO - 10.1080/00015458.2005.11679776

M3 - Article

C2 - 16315842

AN - SCOPUS:27744471890

VL - 105

SP - 533

EP - 536

JO - Acta Chirurgica Belgica

JF - Acta Chirurgica Belgica

SN - 0001-5458

IS - 5

ER -